These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 21715058)
21. Risk factors associated with a thrombotic or bleeding event in patients treated with vitamin K antagonists. Béné J; Dubart AE; Senis C; Auffret M; Caron J; Gautier S J Mal Vasc; 2014 Jul; 39(4):248-55. PubMed ID: 24889788 [TBL] [Abstract][Full Text] [Related]
22. Menace in the mix. Avoiding drug interactions with food, herbs and nutrients. Bancroft B Adv Nurse Pract; 2007 Dec; 15(12):33-7; quiz 38. PubMed ID: 20014671 [No Abstract] [Full Text] [Related]
23. Pharmacogenetics of acenocoumarol: cytochrome P450 CYP2C9 polymorphisms influence dose requirements and stability of anticoagulation. Tàssies D; Freire C; Pijoan J; Maragall S; Monteagudo J; Ordinas A; Reverter JC Haematologica; 2002 Nov; 87(11):1185-91. PubMed ID: 12414349 [TBL] [Abstract][Full Text] [Related]
24. [Acute dyspnea and maculo-papular eruption after taking acenocoumarol (Sintrom]. Kamm W; Berger JP Rev Med Suisse Romande; 1998 Jun; 118(6):565-8. PubMed ID: 9689868 [No Abstract] [Full Text] [Related]
35. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. ; Bousser MG; Bouthier J; Büller HR; Cohen AT; Crijns H; Davidson BL; Halperin J; Hankey G; Levy S; Pengo V; Prandoni P; Prins MH; Tomkowski W; Torp-Pedersen C; Wyse DG Lancet; 2008 Jan; 371(9609):315-21. PubMed ID: 18294998 [TBL] [Abstract][Full Text] [Related]
36. An endogenous foreign body found after subconjunctival hemorrhage. Sze E; Finefrock D; Rosenberg N; Rosenberg M Am J Emerg Med; 2017 Feb; 35(2):376.e3-376.e4. PubMed ID: 27666755 [No Abstract] [Full Text] [Related]
37. Independent predictors of poor vitamin K antagonist control in venous thromboembolism patients. Data from the EINSTEIN-DVT and PE studies. Kooistra HA; Gebel M; Sahin K; Lensing AW; Meijer K Thromb Haemost; 2015 Nov; 114(6):1136-43. PubMed ID: 26224199 [TBL] [Abstract][Full Text] [Related]
38. Overanticoagulation associated with combined use of lactulose and acenocoumarol or phenprocoumon. Visser LE; Penning-van Beest FJ; Wilson JH; Vulto AG; Kasbergen AA; De Smet PA; Hofman A; Stricker BH Br J Clin Pharmacol; 2004 Apr; 57(4):522-4. PubMed ID: 15025752 [TBL] [Abstract][Full Text] [Related]
39. Picture of the month: Coughing paroxysms associated with subconjunctival hemorrhage and dellen. Reisli I; Keles S; Kamis U; Elmas S; Ozturk BT Arch Pediatr Adolesc Med; 2006 Jan; 160(1):53-5. PubMed ID: 16389211 [No Abstract] [Full Text] [Related]
40. Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcome. de Groot MR; Njo TL; van Marwijk Kooy M; Büller HR Clin Lab; 2000; 46(11-12):575-81. PubMed ID: 11109505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]